Amwill Healthcare IPO is a book-built issue worth ₹59.98 crore, consisting of a fresh issue of 44.04 lakh shares totaling ₹48.88 crore and an offer for sale of 10 lakh shares amounting to ₹11.10 crore. The IPO opened for subscription on February 5, 2025, and will close tomorrow on February 7, 2025. The allotment is expected to be finalised on February 10, 2025, with a tentative listing date on BSE SME set for February 12, 2025.
The IPO price band has been set between ₹105 and ₹111 per share. Retail investors need to apply for a minimum lot size of 1,200 shares, requiring an investment of ₹1,33,200. High Net Worth Individuals (HNIs) must invest in at least two lots (2,400 shares), amounting to ₹2,66,400.
Unistone Capital Pvt Ltd is the book-running lead manager for the IPO, while Bigshare Services Pvt Ltd is the registrar. Globalworth Securities Limited is the market maker. Investors can refer to the Red Herring Prospectus (RHP) for comprehensive details on the IPO.
Industry Outlook
- India’s beauty and personal care industry, valued at $14 billion, is experiencing rapid growth due to online retail expansion, premiumisation, and increased demand for organic products. Internet sales in this category surged to $400 million from $100 million in 2014, reflecting the shift towards digital platforms like Nykaa and Amazon.
- The rise in smartphone penetration and internet access among 560 million Indians is further driving industry growth. By 2025, India's internet user base is expected to surpass Europe’s population, accelerating digital engagement and online retailing in beauty and personal care.
Amwill Healthcare IPO Objectives
The company plans to allocate the net proceeds from the issuance to the following purposes:
- ₹2,500 lakh will be allocated to support daily operations, ensuring smooth business activities and financial stability.
- ₹500 lakh will be used to enhance brand visibility and expand market reach through targeted marketing campaigns.
- The remaining funds will be used for general corporate purposes.
About Amwill Healthcare Limited
Amwill Healthcare Limited is a derma-cosmetic development company focused on formulating innovative skincare solutions. By collaborating with contract manufacturers, distributors, and third-party developers, the company has built strong capabilities in manufacturing, packaging, and distribution. The core objective is to develop dermatological, cosmeceutical, and aesthetic products that address specific skin concerns.
Operating primarily in Karnataka, Andhra Pradesh, and Telangana, the company aims to strengthen its presence before expanding into new markets. Its product portfolio is divided into two categories: generic dermatological solutions and specialised formulations for specific skin conditions. The company's expertise in product development is backed by the experience of its Managing Director, Anand Gandhi, who previously operated under M/s. Amwill Healthcare. In 2020, intellectual property rights for the products developed under M/s. Amwill Healthcare was transferred to Amwill Healthcare Limited.
With continuous innovation, 7 new products have been introduced, including XL Hydra Cream, Ultra Kromaglo Effervescent Tablets, and Depimed Ultra Cream. The company collaborates closely with dermatologists and medical professionals to identify market gaps and develop effective formulations for conditions such as acne, fungal infections, and vitiligo.
Manufacturing is outsourced to certified contract manufacturers who ensure quality compliance. The company has also partnered with M/s. Amderma Healthcare LLP for product storage and distribution. This structured approach allows Amwill Healthcare Limited to focus entirely on product research and development while ensuring efficient market penetration.
How To Check the Allotment Status of Amwill Healthcare IPO?
Steps to check IPO allotment status on Angel One’s app:
- Log in to the Angel One app.
- Go to the IPO Section and then to IPO Orders.
- Select the individual IPO that you had applied for and check the allotment status.
- Angel One will notify you of your IPO allotment status via push notification and email.
How To Apply for the Amwill Healthcare IPO Online?
- Login to Your Angel One Account: Open the Angel One app or website and log in with your credentials.
- Locate the IPO Section: Navigate to the 'IPO' section on the platform.
- Select IPO: Find and select the Amwill Healthcare IPO from the list of open IPOs.
- Enter the Lot Size: Specify the number of lots you want to bid for.
- Submit Your UPI ID: Enter your UPI ID to link your payment method and submit your application.
- Approve Funds: Once you receive the bid request on your UPI app, approve it by entering your UPI PIN.
Contact Details of Amwill Healthcare IPO
Registered office: No. 90, 4th Floor, 2nd Main, 7th Cross, Chamrajpet, Bangalore – 560 018, Karnataka, India.
Phone: +91 802 660 5825
E-mail: amwill@amwillhealthcare.com
Amwill Healthcare IPO Reservation
|
Investor Category |
Shares Offered |
|
Anchor Investor |
- |
|
Market Maker |
2,71,200 (5.02%) |
|
QIB |
10,26,000 (18.99%) |
|
NII (HNI) |
20,53,200 (38%) |
|
Retail |
20,53,200 (38%) |
Amwill Healthcare IPO Lot Size
|
Application |
Lots |
Shares |
Amount |
|
Retail (Min) |
1 |
1,200 |
₹1,33,200 |
|
Retail (Max) |
1 |
1,200 |
₹1,33,200 |
|
HNI (Min) |
2 |
2,400 |
₹2,66,400 |
Amwill Healthcare IPO Promoter Holding
The promoters of the company are Anand Gandhi and Tarun Gandhi.
|
Share Holding Pre-Issue |
97.00% |
|
Share Holding Post Issue |
- |
Key Performance Indicators for Amwill Healthcare IPO
As of March 31, 2024, the market capitalisation of Amwill Healthcare's IPO is ₹222.04 crore. Here are the KPIs of Amwill Healthcare:
|
KPI |
Value |
|
RoE (%) |
73.06 |
|
RoCE (%) |
94.16 |
|
Price to Book Value |
10.09 |
|
PAT Margin |
28.53 |
Price Metrics
|
Metric |
Pre-IPO |
Post-IPO |
|
EPS (₹) |
8.04 |
6.52 |
|
P/E (x) |
13.81 |
17.04 |
Note: Pre-IPO EPS is based on pre-issue shareholding as of the RHP date and FY earnings as of March 31, 2024. Post-IPO EPS is based on post-issue shareholding and annualised FY earnings as of September 30, 2024, as per RHP.
Amwill Healthcare IPO Prospectus
Amwill Healthcare IPO Registrar and Lead Managers
Amwill Healthcare IPO Lead Managers
- Unistone Capital Pvt Ltd
Registrar for Amwill Healthcare IPO
Bigshare Services Pvt Ltd
- Contact Number:+91-22-6263 8200
- Email Address: investor@bigshareonline.com
Amwill HealthcareIPO Registrar
Financial Performance of Amwill Healthcare Limited
| Particulars | Year ending on March 31, 2024 | Year ending on March 31, 2023 |
|---|---|---|
| Revenue from Operation (in ₹ lakh) | 4,394.83 | 3,016.63 |
| Profit After Tax (PAT) (in ₹ lakh) | 1,253.63 | 311.44 |
| EPS (Earnings per Share in ₹) | 8.04 | 2.00 |
| Current Ratio (x) | 11.39 | 1.51 |
| Return on equity (%) | 73.06 | 67.67 |
| Return on capital employed (%) | 94.16 | 83.32 |
| EBITDA (in ₹ lakh) | 1,666.69 | 429.56 |
Know before investing
Strengths
8Outsourced manufacturing and distribution reduce costs and enhance flexibility.
Specialises in derma-cosmetic products with innovative formulations.
Promoters have 20+ years of expertise in pharmaceuticals.
Collaborates with contract manufacturers for high-standard product development.
Recently entered West Bengal and Odisha to boost sales.
Strengthening sales team to enhance domestic and international reach.
Uses Amderma Healthcare LLP for seamless product storage and delivery.
Focuses on innovation, new formulations, and market expansion.
Risks
8Amwill Healthcare Limited relies entirely on Amderma Healthcare LLP for revenue.
Any breach of agreement by Amderma Healthcare LLP may harm operations.
Outsourcing manufacturing and distribution increases dependency on third-party service providers.
Limited product innovation may impact future revenue and profitability growth.
Revenue concentration in select states exposes business to regional economic risks.
Failure to collect dues from Amderma Healthcare LLP may impact cash flow.
Credit risk due to extended receivable periods may affect profit margins.
Promoter Group entities engaged in similar businesses may create conflicts of interest.
Amwill Healthcare Limited Peer Comparison
| Company Name | EPS (Basic) | NAV (per share) (₹) | P/E (x) | RoNW (%) |
|---|---|---|---|---|
| Amwill Healthcare Limited | 8.04 | 11 | - | 73.06 |
| Vaishali Pharma Limited | 0.68 | 39.97 | 26.45 | 1.68 |
| Trident Lifeline Limited | 6.13 | 45.81 | 45.06 | 13.37 |
